Needs of Returning Citizens with Substance Use Disorders
May 9, 2025This module covers the various health and social needs of previously incarcerated individuals with substance use disorders upon returning home to their Washington, D.C. communities.
Integrative Harm Reduction Psychotherapy: The Seven Therapeutic Tasks, Skills and Strategies
Integrative Harm Reduction Psychotherapy consists of seven therapeutic tasks: managing the therapeutic alliance, the therapeutic relationship heals, enhancing self-management, assessment as treatment, embracing ambivalence, harm reduction goal setting and personalized planning for positive change.
Cocaine and Methamphetamine Use: Strategies for Addressing Acute Intoxication and Withdrawal
This course discusses the addiction hypothesis behind cocaine and methamphetamine use in order to provide strategies for addressing intoxication and withdrawal.
CDC Clinical Practice Guidelines for Prescribing Opioids for Pain
May 7, 2025This webinar will cover the CDC Clinical Practice Guideline for Prescribing Opioids for Pain, focusing on key recommendations, patient safety strategies, and practical approaches for effective pain management.
Faith in Action: Alternative Harm Reduction Strategies for Youth
April 29, 2025Join us for an insightful and transformative presentation as we explore the intersection of faith, community support, and youth well-being. In this panel discussion, we will examine alternative harm reduction strategies for addressing substance use, mental health challenges, and risky behaviors among young people in our congregational settings.
Ethical and Compassionate Pregnancy Care for Patients Who Use Drugs
April 10, 2025This webinar will explore the ethical and compassionate approaches needed to provide effective care during pregnancy for patients who are using drugs. Focusing on both the health of the patient and their baby, faculty will examine the importance of nonjudgmental, evidence-based practices that support harm reduction, informed choice, and autonomy.
HIVPCP Module 8 | Pharmacy-Based HIV Prevention and PrEP (HIVPCP℞)
April 2, 2025Module 8 of the HealthHIV HIV Prevention Certified Provider Certification Program. Pharmacists who complete the seven core modules of the HealthHIV’s HIVPCP Certification Program along with this newly released Pharmacy-Based HIV Prevention and PrEP module can earn the HIVPCP℞ specialty certification.
HIVPCP Module 7 | State of HIV Prevention and PrEP in 2025: Certification Maintenance for HIVPCPs
Module 7 of the HealthHIV HIV Prevention Certified Provider Certification Program. This course provides an update on the current state of the HIV epidemic, key biomedical advances in HIV prevention, and evidence-based approaches to HIV prevention.
HIVPCP Module 6 | Population-Based Considerations for PrEP
Module 6 of the HealthHIV HIV Prevention Certified Provider Certification Program. This course provides information on population-based considerations for PrEP, including the role of PrEP and TASP with family planning, health models to improve PrEP access, and combination HIV and STI treatment and prevention strategies.
HIVPCP Module 5 | HIV PrEP Adherence and Persistence
Module 5 of the HealthHIV HIV Prevention Certified Provider Certification Program. This course provides insight on vulnerable populations with PrEP disparities, impact of SDOH and barriers to PrEP, navigation models for access, and provider strategies for supporting adherence.
HIVPCP Module 4 | Enhancing Cultural Humility and Understanding Barriers to Care
Module 4 of the HealthHIV HIV Prevention Certified Provider Certification Program. This course provides a review of the HIV care continuum, impact of intersectional stigma on risk, cultural humility, trauma-informed care, and resources to mitigate financial barriers for clients.
HIVPCP Module 3 | Biomedical Strategies for Preventing HIV
Module 3 of the HealthHIV HIV Prevention Certified Provider Certification Program. This course provides an outline for preventing HIV through PEP, PrEP, and TasP, covering clinical basics, research findings, CDC’s guidance on PrEP, and emerging modalities.
